The neutrophil as a mediator of myocardial ischemia-reperfusion injury: Time to move on

Basic Research in Cardiology

Volumn 97, Issue 4, 2002, Pages 268-275

  Baxter, Gary F ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Adhesion molecule; Endothelium; Ischemia; Myocardial infarction; Neutrophil; Polymorphonuclear leukocyte; Reperfusion; Stunning

Indexed keywords

ADENOSINE; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; GRANULOCYTE ANTIBODY; IBUPROFEN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD18; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; STEROID; UNCLASSIFIED DRUG;

BIOACCUMULATION; BLOOD VESSEL INJURY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DISEASE COURSE; DISEASE DURATION; FILTER; HEART ARRHYTHMIA; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HUMAN; LEUKOCYTE ADHERENCE INHIBITION; LEUKOCYTE MIGRATION INHIBITION; MEDIATOR; MEDICAL RESEARCH; MICROVASCULATURE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; REPERFUSION INJURY; REVIEW; STUNNED HEART MUSCLE; VASCULAR ENDOTHELIUM; IMMUNOLOGY;

HUMAN; MYOCARDIAL REPERFUSION INJURY; NEUTROPHILS; HUMANS;

EID: 0035997536     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-002-0366-7     Document Type: Review

References (65)

1. Myeloperoxidase activity as a quantitative marker of polymorphonuclear leukocyte accumulation into an experimental myocardial infarct: The effect of ibuprofen on infarct size and polymorphonuclear leukocyte accumulation
2. Progressive impairment of regional myocardial perfusion after initial restoration of post-ischemic blood flow
3. An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion
4. Double-blind, randomized trial of anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: Limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study
5. 111In-labeled platelet accumulation in infarcted myocardium
6. x analog blocker of the selectin adhesion molecules, on infarct size and "no-reflow" in the rabbit model of acute myocardial infarction/reperfusion
7. The role of neutrophils in myocardial stunning after brief ischaemia: The end of a six year old controversy (1987-1993)
8. Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion
9. Neutrophil accumulation in experimental myocardial infarcts: Relation with extent of injury and effect of reperfusion
10. "Normothermic range" temperature affects myocardial infarct size
11. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury
12. Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease
13. Influence of leukopenia on collateral flow, reperfusion flow, reflow ventricular fibrillation, and infarct size in dogs
14. The contribution of neutrophils to reperfusion arrhythmias and a possible role for antiadhesive pharmacological substances
15. CD18 trials disappoint again
16. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog
17. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog
18. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs
19. Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia
20. Use of anti-ICAM-1 therapy in ischemic stroke: Results of the Enlimomab Acute Stroke Trial
21. Accelerated apoptosis in reperfused myocardium: Friend or foe?
22. The inflammatory response in myocardial infarction
23. x analogue does not reduce myocardial infarct size after ischemia and reperfusion in dogs
24. Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury
25. Adenosine infusion during early reperfusion failed to limit infarct size in a collateral deficient species
26. The leukocyte cell adhesion cascade and its role in myocardial ischemia-reperfusion injury
27. Protection of ischemic/reperfused canine myocardium by CL18/6, a monoclonal antibody to adhesion molecule ICAM-1
28. Perfusion contraction match and mismatch
29. The phlogistic role of C3 leukotactic fragments in myocardial infarcts in rats
30. Combined adenosine and lidocaine administration limits myocardial reperfusion injury
31. Lethal reperfusion injury: Fact or fancy?
32. Myocardial reperfusion injury: Insights gained from gene-targeted mice
33. Severe neutrophil depletion by leukocyte filters or cytotoxic drug does not improve the recovery of contractile function in porcine stunned myocardium
34. Studies in infarction. IV. Experimental bland infarction of the myocardium, myocardial regeneration and cicatrization
35. x)
36. Molecular and cellular aspects of re-entrant arrhythmias
37. The "no-reflow" phenomenon after temporary coronary occlusion in dogs
38. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury
39. The role of neutrophils and free radicals in ischemic myocardial injury
40. The speed of healing of myocardial infarction: A study of the pathologic anatomy in 72 cases
41. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion
42. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium
43. Role of leukocytes in acute myocardial infarction in anesthetized dogs: Relationship to myocardial salvage by anti-inflammatory drugs
44. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no-reflow phenomenon
45. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period
46. The "no-reflow" phenomenon: Basic science and clinical correlates
47. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow
48. Animal Models for Protecting Ischemic Myocardium: Results of the NHLBI Cooperative Study. Comparisons of unconscious and conscious dog models
49. The role of neutrophils and free radicals in the ischemic-reperfused heart: Why the confusion and controversy?
50. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog
51. The effect of ibuprofen on accumulation of indium-111-labeled platelets and leukocytes in experimental myocardial infarction
52. An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study)
53. The transmural progression of the no-reflow phenomenon in globally ischemic hearts
54. Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation
55. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mol, anti-CD11b) that inhibits leukocyte adhesion
56. Time course of regional flow distribution following reperfusion of the isolated ischaemic rat heart
57. Experimental acute myocardial infarction. Histologic and histochemical studies of early myocardial infarcts induced by temporary or permanent occlusion of a coronary artery
58. Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs
59. Studies on experimental coronary occlusion. Chemical and anatomical changes in the myocardium after coronary ligation
60. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs
61. Effect of duration of ischaemia on reduction of myocardial infarct size by inhibition of neutrophil accumulation using an anti-CD18 monoclonal antibody
62. Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP579 administered at reperfusion
63. Rat and rabbit heart infarction: Effects of anesthesia, perfusate, risk zone and method of infarct sizing
64. x
65. Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins